SACT INTERNATIONAL Co., LTD. Report issue

For profit Phase 4
Founded: Saudi Arabia (2014)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

clindamycin (cleocin) (1 trial)

levonadifloxacin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2